Question 1

What is the catalog number for MAPRE2, NT (MAPRE2, RP1, Microtubule-associated protein RP/EB family member 2, APC-binding protein EB2, End-binding protein 2) (MaxLight 550) discontinued?

Accepted Answer

The catalog number for MAPRE2, NT (MAPRE2, RP1, Microtubule-associated protein RP/EB family member 2, APC-binding protein EB2, End-binding protein 2) (MaxLight 550) discontinued is 038191-ML550.

Question 2

What sizes are available for MAPRE2, NT (MAPRE2, RP1, Microtubule-associated protein RP/EB family member 2, APC-binding protein EB2, End-binding protein 2) (MaxLight 550) discontinued?

Accepted Answer

MAPRE2, NT (MAPRE2, RP1, Microtubule-associated protein RP/EB family member 2, APC-binding protein EB2, End-binding protein 2) (MaxLight 550) discontinued

Selected Variant

038191-ML550

Size: 100 µL

Product Specifications

Clonality

Pab

Question 3

Is MAPRE2, NT (MAPRE2, RP1, Microtubule-associated protein RP/EB family member 2, APC-binding protein EB2, End-binding protein 2) (MaxLight 550) discontinued in stock?

Accepted Answer

MAPRE2, NT (MAPRE2, RP1, Microtubule-associated protein RP/EB family member 2, APC-binding protein EB2, End-binding protein 2) (MaxLight 550) discontinued

Selected Variant

038191-ML550

Size: 100 µL

Product Specifications

Clonality

Pab

Question 4

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

Question 5

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

Question 6

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.